• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞动脉炎患者感染的发生率:一项队列研究。

Incidence of infections in patients with giant cell arteritis: a cohort study.

机构信息

Centre Hospitalier de l'Universtité de Montréal, Montreal, Quebec, Canada.

出版信息

Arthritis Care Res (Hoboken). 2012 Apr;64(4):581-8. doi: 10.1002/acr.21569.

DOI:10.1002/acr.21569
PMID:22184094
Abstract

OBJECTIVE

Giant cell arteritis (GCA) is the most frequent form of vasculitis in adults. We sought to estimate the infectious risk associated with GCA and its treatment.

METHODS

We conducted a matched historical cohort study using data from The Health Improvement Research Network. Patients with newly diagnosed GCA were matched with up to 6 non-GCA patients by age, sex, general practice, and date of entry into the cohort. Random-effects Poisson regression models were used to obtain incidence rates and rate ratios for lower respiratory tract infections (LRTI), urinary tract infections (UTI), and sepsis, as well as for the subset of these that comprised serious infections (pneumonias, upper UTI, and sepsis). Effect modification by age, sex, and time since diagnosis of GCA was assessed.

RESULTS

A total of 1,664 patients with GCA were matched to 8,078 patients without GCA. Overall, 805 (48%) of the GCA patients and 3,007 (37%) of the non-GCA patients experienced ≥1 episode of systemic infection during followup, with adjusted rate ratios for LRTI, UTI, and serious infections of 1.48 (95% confidence interval [95% CI] 1.34-1.65), 1.27 (95% CI 1.10-1.46), and 1.55 (95% CI 1.22-1.96), respectively (P < 0.001 for all). The rate ratio for sepsis was 1.63 (95% CI 0.78-3.40, P = 0.20). Rate ratios for infection were highest in the first 6 months following diagnosis of GCA and in patients age <75 years, but did not vary by sex.

CONCLUSION

This is the first study to show that patients with GCA are at increased risk of systemic infections, particularly in the first few months following diagnosis. New GCA medications that allow steroid sparing are needed to treat this condition.

摘要

目的

巨细胞动脉炎(GCA)是成人中最常见的血管炎形式。我们旨在评估 GCA 及其治疗相关的感染风险。

方法

我们使用来自健康改善研究网络的数据进行了匹配的历史性队列研究。新诊断为 GCA 的患者与年龄、性别、全科医生和进入队列日期相匹配的多达 6 名非 GCA 患者相匹配。采用随机效应泊松回归模型,获得下呼吸道感染(LRTI)、尿路感染(UTI)和败血症的发病率和率比,以及这些感染中包含严重感染(肺炎、上尿路感染和败血症)的发病率和率比。评估了年龄、性别和 GCA 诊断后时间的效应修饰作用。

结果

共有 1664 名 GCA 患者与 8078 名非 GCA 患者相匹配。在整个随访期间,805 名(48%)GCA 患者和 3007 名(37%)非 GCA 患者发生了≥1 次全身感染,LRTI、UTI 和严重感染的调整后率比分别为 1.48(95%置信区间[95%CI]1.34-1.65)、1.27(95%CI 1.10-1.46)和 1.55(95%CI 1.22-1.96)(均<0.001)。败血症的率比为 1.63(95%CI 0.78-3.40,P=0.20)。GCA 诊断后前 6 个月和年龄<75 岁的患者感染率最高,但性别无差异。

结论

这是第一项表明 GCA 患者发生全身感染风险增加的研究,尤其是在诊断后最初几个月内。需要新的可节省类固醇的 GCA 药物来治疗这种疾病。

相似文献

1
Incidence of infections in patients with giant cell arteritis: a cohort study.巨细胞动脉炎患者感染的发生率:一项队列研究。
Arthritis Care Res (Hoboken). 2012 Apr;64(4):581-8. doi: 10.1002/acr.21569.
2
Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.巨细胞动脉炎的住院感染:一项基于人群的回顾性队列研究。
J Rheumatol. 2014 Dec;41(12):2447-51. doi: 10.3899/jrheum.140124. Epub 2014 Oct 15.
3
Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.巨细胞动脉炎病程中严重感染和感染相关死亡率的发生率:一项多中心、前瞻性、双队列研究。
Arthritis Rheumatol. 2016 Jun;68(6):1477-82. doi: 10.1002/art.39596.
4
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.巨细胞动脉炎患者中与皮质类固醇治疗潜在相关的结局发生率。
Semin Arthritis Rheum. 2017 Apr;46(5):650-656. doi: 10.1016/j.semarthrit.2016.10.001. Epub 2016 Oct 13.
5
Infections and the risk of incident giant cell arteritis: a population-based, case-control study.感染与巨细胞动脉炎发病风险:基于人群的病例对照研究。
Ann Rheum Dis. 2017 Jun;76(6):1031-1035. doi: 10.1136/annrheumdis-2016-210152. Epub 2016 Nov 28.
6
Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.巨细胞动脉炎与血管疾病——风险因素及预后:一项使用英国临床实践研究数据链的队列研究
Rheumatology (Oxford). 2017 May 1;56(5):753-762. doi: 10.1093/rheumatology/kew482.
7
Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.巨细胞动脉炎患者的住院率及医疗服务利用情况:一项基于1987年至2012年人群的研究。
Semin Arthritis Rheum. 2015 Aug;45(1):70-4. doi: 10.1016/j.semarthrit.2015.02.010. Epub 2015 Mar 3.
8
Mortality in Patients With Giant Cell Arteritis: A Cohort Study in UK Primary Care.巨细胞动脉炎患者的死亡率:英国初级保健中的队列研究。
Arthritis Care Res (Hoboken). 2018 Aug;70(8):1251-1256. doi: 10.1002/acr.23538. Epub 2018 May 28.
9
Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.巨细胞动脉炎的发病率和患者特征:基于共病数据驱动的分析。
Arthritis Care Res (Hoboken). 2015 Mar;67(3):390-5. doi: 10.1002/acr.22429.
10
Infections Are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden.感染与巨细胞动脉炎风险增加相关:来自瑞典南部的基于人群的病例对照研究。
J Rheumatol. 2021 Feb;48(2):251-257. doi: 10.3899/jrheum.200211. Epub 2020 May 15.

引用本文的文献

1
Bacterial Infections Associated with Immunosuppressive Agents Commonly Used in Patients with Interstitial Lung Diseases.与间质性肺疾病患者常用免疫抑制剂相关的细菌感染
Pathogens. 2023 Mar 15;12(3):464. doi: 10.3390/pathogens12030464.
2
Analysis of Emergency Department Visits by Patients With Giant Cell Arteritis: A National Population-Based Study.巨细胞动脉炎患者急诊科就诊情况分析:一项基于全国人群的研究。
Cureus. 2023 Feb 17;15(2):e35121. doi: 10.7759/cureus.35121. eCollection 2023 Feb.
3
Burden, Causes, and Outcomes of Hospitalization in Patients With Giant Cell Arteritis: A US National Cohort Study.
巨细胞动脉炎患者住院的负担、病因和结果:一项美国全国队列研究。
Arthritis Care Res (Hoboken). 2023 Aug;75(8):1830-1837. doi: 10.1002/acr.25081. Epub 2023 Feb 28.
4
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering.机器学习在预测糖皮质激素减量后巨细胞动脉炎发作中的有效性。
Front Immunol. 2022 Apr 5;13:860877. doi: 10.3389/fimmu.2022.860877. eCollection 2022.
5
Giant cell arteritis treatment patterns and rates of serious infections.巨细胞动脉炎的治疗模式和严重感染发生率。
Clin Exp Rheumatol. 2022 May;40(4):826-833. doi: 10.55563/clinexprheumatol/uonz1p. Epub 2021 Dec 13.
6
[Rare superinfection in a COVID-19 patient-A chronology].[一名新冠病毒肺炎患者的罕见二重感染——病例记录]
Anaesthesist. 2022 Jan;71(1):38-49. doi: 10.1007/s00101-021-01018-2. Epub 2021 Aug 24.
7
Large-vessel involvement is predictive of multiple relapses in giant cell arteritis.大血管受累可预测巨细胞动脉炎的多次复发。
Ther Adv Musculoskelet Dis. 2021 May 18;13:1759720X211009029. doi: 10.1177/1759720X211009029. eCollection 2021.
8
Effects of the COVID-19 Pandemic on Patients Living With Vasculitis.新冠疫情对血管炎患者的影响。
ACR Open Rheumatol. 2021 Jan;3(1):17-24. doi: 10.1002/acr2.11204. Epub 2020 Dec 8.
9
Evaluation of Urinary Tract Infection following Corticosteroid Therapy in Patients with Multiple Sclerosis Exacerbation.多发性硬化症急性发作患者接受皮质类固醇治疗后尿路感染的评估
Can J Infect Dis Med Microbiol. 2021 Jan 31;2021:6616763. doi: 10.1155/2021/6616763. eCollection 2021.
10
Outcome of Patients With Necrotizing Vasculitis Admitted to the Intensive Care Unit (ICU) for Sepsis: Results of a Single-Centre Retrospective Analysis.入住重症监护病房(ICU)治疗脓毒症的坏死性血管炎患者的转归:一项单中心回顾性分析的结果。
J Intensive Care Med. 2021 Dec;36(12):1410-1416. doi: 10.1177/0885066620953768. Epub 2020 Sep 2.